Emma E. Vincent
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 13
- Cancer, Lipids, and Metabolism 6
- Immunology top 2%
- Molecular Biology top 2%
- Metabolism, Diabetes, and Cancer 12
- Epigenetics and DNA Methylation 5
- PI3K/AKT/mTOR signaling in cancer 4
- Biological Psychiatry top 5%
- Oncology top 5%
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 10
- Respiratory Support and Mechanisms 6
-
- Genetic Associations and Epidemiology 7
- Co-authors
- Jeremy M. TavaréIngeborg HersRussell G. JonesTakla GrissBrandon FaubertJulianna BlagihAlexey SergushichevMaxim N. Artyomov
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Emma E. Vincent
69 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Cancer Research 1.4k
- Immunology 1.2k
- Molecular Biology 3.1k
- Biological Psychiatry 96
- Oncology 674
Countries citing papers authored by Emma E. Vincent
This map shows the geographic impact of Emma E. Vincent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma E. Vincent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma E. Vincent more than expected).
Fields of papers citing papers by Emma E. Vincent
This network shows the impact of papers produced by Emma E. Vincent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma E. Vincent. The network helps show where Emma E. Vincent may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emma E. Vincent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 15 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 2 | |
| 10 | 2021 | 135 | |
| 11 | 2019 | 16 | |
| 12 | 2019 | 21 | |
| 13 | 2018 | 17 | |
| 14 | 2018 | 75 | |
| 15 | Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammationbreakdown → | 2016 | 1075 |
| 16 | 2015 | 83 | |
| 17 | PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancerbreakdown → | 2015 | 437 |
| 18 | 2015 | 204 | |
| 19 | 2008 | 66 | |
| 20 | 2007 | 14 |
About Emma E. Vincent
Emma E. Vincent is a scholar working on Cancer Research, Applied Microbiology and Biotechnology and Otorhinolaryngology, having authored 71 papers that have together received 5.6k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (13 papers), Metabolism, Diabetes, and Cancer (12 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers), Genetic Associations and Epidemiology (7 papers), Respiratory Support and Mechanisms (6 papers), Cancer, Lipids, and Metabolism (6 papers), Epigenetics and DNA Methylation (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Cancer Research (1.4k citations), Immunology (1.2k citations) and Molecular Biology (3.1k citations). Emma E. Vincent has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Jeremy M. Tavaré, Ingeborg Hers, Russell G. Jones, Takla Griss, Brandon Faubert, Julianna Blagih, Alexey Sergushichev, Maxim N. Artyomov, Maya C. Poffenberger and Ekaterina Loginicheva. Their work appears in journals such as Nature Communications, PLoS ONE, Cell Metabolism, PLoS Medicine and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.